Mostrar el registro sencillo del ítem

dc.contributor.authorStromsnes, Kristine
dc.contributor.authorMartinez Fajardo, Cristian
dc.contributor.authorSoto Rodriguez, Silvana
dc.contributor.authorUlrika Kajander, Erika Ria
dc.contributor.authorLupu, Remus Iulian
dc.contributor.authorPozo Rodriguez, Monica
dc.contributor.authorBoira Nacher, Balma
dc.contributor.authorFont Alberich, Maria
dc.contributor.authorGambini Castell, Marcos
dc.contributor.authorOlaso Gonzalez, Gloria
dc.contributor.authorGomez Cabrera, Maria Carmen
dc.contributor.authorGambini, Juan
dc.date.accessioned2024-12-20T10:56:52Z
dc.date.available2024-12-20T10:56:52Z
dc.date.issued2024-12-16
dc.identifier.citationStromsnes, K. et. al. Pharmaceuticals 2024, 17, 1697. [https://doi.org/10.3390/ph17121697]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/98354
dc.description.abstractOsteoporosis is a chronic disease that is characterized by a loss of bone density, which mainly affects the microstructure of the bones due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one of the pandemics of the 21st century, affecting around 200 million people. Its most serious consequence is an increased risk of bone fractures, thus making osteoporosis a major cause of disability and even premature death in the elderly. In this review, we discuss its causes, the biochemical mechanisms of bone regeneration, risk factors, pharmacological treatments, prevention and the effects of diet, focusing in this case on compounds present in a diet that could have palliative and preventive effects and could be used as concomitant treatments to drugs, which are and should always be the first option. It should be noted as a concluding remark that non-pharmacological treatments such as diet and exercise have, or should have, a relevant role in supporting pharmacology, which is the recommended prescription today, but we cannot ignore that they can have a great relevance in the treatment of this disease.es_ES
dc.description.sponsorshipInstituto de Salud Carlos III CB16/10/00435 (CIBERFES); PID2022-142470OB-I00 funded by MICIU/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe”es_ES
dc.description.sponsorshipPROMETEO (CIPROM/2022/56)-“Consellería de Educación, Universidades, y Empleo de la Generalitat Valenciana”es_ES
dc.description.sponsorshipRed EXERNET-RED DE EJERCICIO FISICO Y SALUD (RED2022-134800-T) Agencia Estatal de Investigación (Ministerio de Ciencias e Innovación)es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectosteoporosis es_ES
dc.subjectrisk factorses_ES
dc.subjectpolyphenolses_ES
dc.titleOsteoporosis: Causes, Mechanisms, Treatment and Prevention: Role of Dietary Compoundses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/ph17121697
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional